BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

...the ePlex SARS-CoV-2 test from GenMark Diagnostics Inc. and the Simplexa COVID-19 Direct test from DiaSorin...
...practitioner. Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Virginia Li, Associate Editor COVID-19 GenMark Diasorin Aperiomics CTK Scanwell EverlyWell COVID-19...
BioCentury | Mar 13, 2020
Politics, Policy & Law

U.S. moves to unlock COVID-19 test capacity

...authorizing certain laboratories in New York to begin patient testing” for COVID-19. BARDA funding Qiagen, DiaSorin...
...DiaSorin Molecular LLC to develop systems that could provide COVID-19 test results in one hour. DiaSorin's...
...Direct technology, a platform FDA has cleared for influenza and respiratory syncytial virus (RSV) tests. DiaSorin...
BioCentury | Apr 18, 2016
Company News

Quest Diagnostics, DiaSorin deal

...this quarter. The companies did not respond to inquiries. Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. DiaSorin S.p.A....
BioCentury | Oct 29, 2012
Company News

DiaSorin, MorphoSys deal

...Diagnostic company DiaSorin received rights to two undisclosed, recombinant HuCAL antibodies from MorphoSys' AbD Serotec research...
...is eligible for royalties. MorphoSys declined to disclose details, while DiaSorin could not be reached. DiaSorin S.p.A....
BioCentury | Nov 1, 2010
Company News

Orexo management update

...of its Kibion AB subsidiary, effective Nov. 15, formerly general manager of clinical diagnostics at Diasorin S.p.A....
BioCentury | Jul 12, 2010
Company News

DiaSorin, Meridian Bioscience deal

...will use Meridian's technology to develop infectious disease diagnostics for use on Diasorin's LIAISON technology. Diasorin...
...and Helicobacter pylori. Meridian is eligible to receive royalties on products developed under the deal. Diasorin S.p.A....
BioCentury | Oct 22, 2007
Company News

Glycominds board of directors update

...Autoimmune, Microarrays Appointed: Chen Evans, a director and senior corporate VP of commercial operations at DiaSorin S.p.A....
BioCentury | Jul 30, 2007
Company News

Dade Behring, DiaSorin S.p.A., Roche, Siemens deal

...deal is expected to close in 2Q08. Separately, DADE and ROG's Roche Diagnostics subsidiary granted DiaSorin...
...detect HIV-1 group O. Financial terms were not disclosed. Dade Behring Inc. (DADE), Deerfield, Ill. DiaSorin S.p.A....
Items per page:
1 - 8 of 8
BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

...the ePlex SARS-CoV-2 test from GenMark Diagnostics Inc. and the Simplexa COVID-19 Direct test from DiaSorin...
...practitioner. Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Virginia Li, Associate Editor COVID-19 GenMark Diasorin Aperiomics CTK Scanwell EverlyWell COVID-19...
BioCentury | Mar 13, 2020
Politics, Policy & Law

U.S. moves to unlock COVID-19 test capacity

...authorizing certain laboratories in New York to begin patient testing” for COVID-19. BARDA funding Qiagen, DiaSorin...
...DiaSorin Molecular LLC to develop systems that could provide COVID-19 test results in one hour. DiaSorin's...
...Direct technology, a platform FDA has cleared for influenza and respiratory syncytial virus (RSV) tests. DiaSorin...
BioCentury | Apr 18, 2016
Company News

Quest Diagnostics, DiaSorin deal

...this quarter. The companies did not respond to inquiries. Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. DiaSorin S.p.A....
BioCentury | Oct 29, 2012
Company News

DiaSorin, MorphoSys deal

...Diagnostic company DiaSorin received rights to two undisclosed, recombinant HuCAL antibodies from MorphoSys' AbD Serotec research...
...is eligible for royalties. MorphoSys declined to disclose details, while DiaSorin could not be reached. DiaSorin S.p.A....
BioCentury | Nov 1, 2010
Company News

Orexo management update

...of its Kibion AB subsidiary, effective Nov. 15, formerly general manager of clinical diagnostics at Diasorin S.p.A....
BioCentury | Jul 12, 2010
Company News

DiaSorin, Meridian Bioscience deal

...will use Meridian's technology to develop infectious disease diagnostics for use on Diasorin's LIAISON technology. Diasorin...
...and Helicobacter pylori. Meridian is eligible to receive royalties on products developed under the deal. Diasorin S.p.A....
BioCentury | Oct 22, 2007
Company News

Glycominds board of directors update

...Autoimmune, Microarrays Appointed: Chen Evans, a director and senior corporate VP of commercial operations at DiaSorin S.p.A....
BioCentury | Jul 30, 2007
Company News

Dade Behring, DiaSorin S.p.A., Roche, Siemens deal

...deal is expected to close in 2Q08. Separately, DADE and ROG's Roche Diagnostics subsidiary granted DiaSorin...
...detect HIV-1 group O. Financial terms were not disclosed. Dade Behring Inc. (DADE), Deerfield, Ill. DiaSorin S.p.A....
Items per page:
1 - 8 of 8